header”></head>

<body class=

About admin

This author has not yet filled in any details.
So far admin has created 35 blog entries.

NHSN Data – Due Sept. 30

To meet the CMS ESRD QIP NHSN reporting requirements for Payment Year 2021, outpatient hemodialysis clinics must submit their second quarter 2019 Dialysis Event data collected from April 1st, 2019 through June 30th, 2019, by Monday, September 30, 2019. New or revised second quarter data entered into NHSN after September 30th will not be sent to

By | September 17th, 2019|Uncategorized|Comments Off on NHSN Data – Due Sept. 30

Promising Practice Alert

Have you been struggling to find a way to include the Patient Voice in your QAPI meetings? The Network encourages you to invite patients to your monthly quality meetings. In order to get patients involved, you must educate them about the purpose of the meeting. We’ve created this QAPI Patient Invitation to do just that!

By | September 17th, 2019|Uncategorized|Comments Off on Promising Practice Alert

ESRD Medicare Timeline

Medicare Entitlement and 30 Month Coordination Period Begins Medicare starts on first day of fourth month of Hemodialysis Medicare goes back to 1st day of month that Peritoneal Dialysis began Medicare goes back to 1st day of month that kidney transplant is received Medicare pays after your insurance does, it pays deductibles and copays Medicare

By | September 16th, 2019|Uncategorized|Comments Off on ESRD Medicare Timeline

Medicare Part D – Medicare Drug Plans

Medicare prescription drug coverage is an optional benefit offered to everyone who has Medicare. If you decide not to get Medicare Part D when you’re first eligible, you will likely pay a late enrollment penalty if you join later. There are two ways you can get drug coverage: Medicare Prescription Drug Plan (Part D). These

By | September 16th, 2019|Medicare Part D|Comments Off on Medicare Part D – Medicare Drug Plans

Fresenius Kabi Recalls Volumat MC Agilia Infusion Pump and Vigilant Agilia Drug Library

The FDA has identified this as a Class I recall, the most serious type of recall.  Use of these devices may cause serious injuries or death. Recalled Product Volumat MC Agilia Infusion System and Vigilant Drug LibraryModelsVolumat MC Agilia Z021135, Software Versions 1.7 and 1.9aVigilant Drug Library Z073476, Software Versions 1.0 and 1.1Lot Numbers: AllManufacturing

By | August 15th, 2019|alerts|0 Comments

Par Pharmaceutical, Inc. Issues Voluntary Nationwide Recall of One Lot of Mycophenolate Mofetil for Injection

Endo International plc, announced today that one of its operating companies, Par Pharmaceutical, Inc., is voluntarily recalling one lot of Mycophenolate Mofetil for Injection, USP to the hospital and retail pharmacy level. One vial of product was observed containing a glass fragment after reconstitution. The administration of a glass particulate, if present in an intravenous

By | May 8th, 2019|alerts|0 Comments

Teva Pharmaceuticals USA Issues Voluntary Nationwide Recall

Teva Pharmaceuticals has initiated a voluntary recall in the United States, to the patient level, of all lots of Amlodipine / Valsartan combination tablets and Amlodipine / Valsartan / Hydrochlorothiazide combination tablets due to an impurity detected above specification limits in an active pharmaceutical ingredient (API) manufactured by Mylan India. The impurity found in Mylan’s

By | December 3rd, 2018|alerts|0 Comments

Hospira Issues Voluntary Nationwide Recall

Hospira, Inc., a Pfizer company, is voluntarily recalling 8 lots of Hospira’s Daptomycin for Injection 500 mg, Lyophilized Powder For Solution, Single Dose Vial (NDC 0409-0106-01) to the Hospital/Retail level. The product is being recalled due to adverse event reports indicative of infusion reactions. Daptomycin for Injection has been associated with reports of adverse events indicative of

By | July 18th, 2018|alerts|0 Comments

HeartMate 3™ Left Ventricular Assist System: Class I Recall

HeartMate 3™ Left Ventricular Assist System: Class I Recall - Due to Potential Malfunction that may Lead to Graft Occlusion The class I recall is due to a malfunction in the device’s outflow graft assembly that may cause the outflow graft to twist and close up (occlusion) over time. Occlusion of the outflow graft can

By | May 25th, 2018|alerts|0 Comments